Episode Summary
Executive Summary: David Roberts explains a sudden personal-health disruption that will slow Volts: he and his family have COVID, and he has been diagnosed with low-grade urothelial carcinoma in his right kidney cavity, with surgery scheduled to remove the kidney. He frames the news with gratitude, reassurance about prognosis, and an acknowledgment that podcasts may become more sporadic while he recovers and manages tendonitis.
Main Topics: Personal health update and cancer diagnosis (Priority: 5/5): Roberts shares that he has urothelial carcinoma in his right kidney cavity, discovered on a CT scan, and that surgery to remove the kidney is planned for next month. He emphasizes the cancer is low grade but still requires removal. Family COVID outbreak and canceled Italy trip (Priority: 5/5): The planned family vacation to Italy for his son’s graduation celebration is canceled after the entire family tests positive for COVID, turning a major milestone trip into a stay-at-home recovery period. Impact on work and production schedule (Priority: 5/5): Roberts says cancer treatment, COVID, and worsening wrist/elbow tendonitis will reduce his ability to do longer writing and may make podcast releases more irregular. Medical outlook and treatment rationale (Priority: 4/5): He explains the tradeoff between repeated laser surgeries versus taking out the kidney entirely, noting the tumor’s size makes nephrectomy the practical choice despite the cancer being low grade. Gratitude, perspective, and community support (Priority: 4/5): He reassures listeners that his prognosis and support system are good, thanks subscribers for sticking with him, and notes that Volts is something that keeps him going. Future plans for Volts (Priority: 3/5): Roberts says he hopes to return to long-form writing, bring in guest pieces, do deeper dives, and create recurring features once he gets through the current difficulties.
Key Arguments: The cancer is low grade, but its size makes kidney removal the best treatment option rather than repeated laser procedures. He is not in pain and currently has few symptoms beyond hematuria, which helped detect the tumor. The combination of COVID, upcoming surgery, and tendonitis will temporarily reduce his output and make the podcast less regular. Despite the setbacks, he has strong odds of recovery, good medical care, insurance, and family support. He wants subscribers to feel free to unsubscribe if the altered format no longer meets their expectations.
Data Points: Tumor size: 4.5 centimeter - Mass in the right kidney cavity Family COVID status: 4 family members positive - Older son, then Roberts, then wife and younger son tested positive Upcoming surgery: Next month - Scheduled robot-assisted nephrectomy Vacation destination: Italy - Trip canceled due to illness and diagnosis Duration of prior diagnosis awareness: About a month ago - CT scan identified the mass around a month before the message Possible repeated surgeries avoided: 2-3+ full surgeries - Roberts says laser treatment could require multiple surgeries followed by lifelong vigilance Symptom noted: Hematuria - Bloody urine was the only symptom that led to discovery Work limitation: ~30 seconds - Holding hands steady longer than this causes sharp pain due to tendonitis
Pivotal Quotes: "I have cancer. Specifically, I have a relatively rare cancer called urothelial carcinoma" — David Roberts: He reveals the reason for the canceled vacation and reduced work capacity "The good news is that, somewhat to everyone's surprise, the biopsy indicates that the cancer is low grade." — David Roberts: He explains the biopsy result and why the prognosis is relatively favorable "I will get my kidney out. COVID will pass. I will figure out how to deal with the tendonitis someday soon." — David Roberts: He offers reassurance and frames the situation as temporary
Implications: Volts may have slower, less predictable publishing while Roberts recovers, but the outlook is encouraging. Listeners should expect more audio-first, lighter output for a while, with a likely return to deeper clean-energy coverage after treatment.